IIPR Q2 2026: We retain our POTENTIAL SELL, modest execution not yet thesis-changing

What happened

In Q2 2026, IIPR completed its $270 million investment in IQHQ and reported improved leasing activity, accompanied by balance sheet strengthening that likely addresses the looming 2026 debt maturity. While management's tone is constructive, these actions align with the prior defensive strategy of diversifying income and shoring up liquidity amid ongoing cannabis tenant stress. The base case from our earlier report expected gradual re-tenanting progress and IQHQ income to partially offset defaults, and the Q2 update suggests modest execution on that path. However, the core risk remains: AFFO per share likely still trails the $1.90 dividend, and the cannabis portfolio's health depends on wholesale pricing and operator access to capital. Without confirmation of stabilized AFFO coverage, the dividend still appears reliant on external funding, maintaining downward pressure on per-share value.

Implication

The Q2 update shows IIPR executing its diversification and refinancing plans, which lowers the probability of an imminent liquidity crisis. However, the underlying cannabis portfolio remains under duress, and the dividend is still funded partly by capital maneuvers rather than organic cash flow. Investors should view the news as an incremental positive that buys time, not a fundamental turnaround, and maintain a defensive stance with a trim target above $60.

Thesis delta

Execution on IQHQ funding and balance sheet strengthening reduces the likelihood of a worst‑case near‑term liquidity event, but does not alter the core view that AFFO per share remains below the dividend and tenant stress is unresolved. Our base‑case probability of gradual re‑tenanting improves slightly, yet the overhang of a potential dividend reset keeps the risk/reward skewed negatively.